Clinical Trial Update: Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of celecoxib for progressive metastatic differentiated thyroid cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED